ADVFN US – Market Content Editor
-
NEW Investor Insights: Introducing The Watchlist on Investors Hub
We’re excited to announce the launch of our newest tool for the Investors Hub community: The Watchlist. This innovative feature is designed to give you, the real-time investor, direct access to the information you need to make informed decisions faster than ever. In today’s fast-paced market, cutting through the noise is a challenge. While charts…
-
Soligenix Shares Surge After FDA Grants Orphan Drug Status
Soligenix (NASDAQ:SNGX) stock skyrocketed 88% after the FDA awarded orphan drug designation to dusquetide, the active component of SGX945, for the treatment of Behçet’s Disease. The designation follows the FDA’s evaluation of recent Phase 2a clinical trials, which demonstrated both biological efficacy and safety in patients with this rare autoimmune disorder. Orphan drug status provides…
-
Applied Digital Shares Jump 17% After $3 Billion AI Campus Announcement
Applied Digital (NASDAQ:APLD) saw its stock surge 17% following news of plans to develop a $3 billion AI computing campus in North Dakota, aiming to expand capacity to meet rising demand for AI processing power. Construction on the Polaris Forge 2 facility, a 280-megawatt AI Factory near Harwood, North Dakota, is slated to begin in…
-
Strategy Expands Bitcoin Holdings with $51 Million Acquisition
Strategy (NASDAQ:MSTR), under the leadership of Michael Saylor, added 430 BTC to its portfolio last week, paying an average of $119,666 per coin for a total outlay of roughly $51.4 million. The company’s total Bitcoin balance now stands at 629,376 BTC, acquired at an average price of $73,320 per unit. The current market value of…
-
BitMine Boosts Ethereum Holdings, Crypto Portfolio Tops $6.6 Billion
BitMine Immersion Technologies (AMEX:BMNR) revealed that its cryptocurrency portfolio has now exceeded $6.61 billion, making it the largest Ethereum (COIN:ETHUSD) reserve globally and the second-largest crypto stash overall, trailing only Strategy Inc. (NASDAQ:MSTR). The company currently holds 1.52 million ETH alongside 192 BTC. In a major acquisition last week, BitMine added 373,110 ETH to its…
-
Google Shares Could Swing 10% Following DoJ Ruling, Says BMO
Alphabet (NASDAQ:GOOGL), Google’s parent company, may see its stock fluctuate by as much as 10% in either direction depending on the Department of Justice’s upcoming decision regarding its search monopoly case, according to analysts at BMO Capital. BMO Capital noted that the U.S. District Court has already found Google guilty of “illegally maintaining its search…
-
Tesla Confirms Upcoming Launch of Six-Seater Model Y L in China
Tesla (NASDAQ:TSLA) revealed Monday that its Model Y L will be “coming soon” to the Chinese market. The company shared the update via a post on Weibo (NASDAQ:WB), a widely used social media platform in China. Tesla had earlier registered plans to bring this new six-seater electric vehicle to China, although the announcement did not…
-
Palantir Shares Dip After Citron Research Flags Valuation Concerns
Palantir Technologies (NYSE:PLTR) slipped 2% Monday morning following a cautious assessment from short seller Citron Research regarding the company’s stock valuation, marking the second time the firm has raised concerns. The decline comes in the wake of remarks from OpenAI CEO Sam Altman, who warned that the AI market is in a bubble. This statement,…
-
iRhythm Shares Dip Following Short Report from Spruce Point
iRhythm Technologies (NASDAQ:IRTC) dropped 2% Monday morning after Spruce Point Capital Management released a short report targeting the cardiac monitoring company. The report, titled “Investor Complacency is Off the Charts,” suggested that iRhythm shares could face 40%-70% long-term downside, projecting a potential trading range of roughly $43 to $94 per share. Spruce Point raised concerns…
-
GoodRx Shares Surge After Novo Nordisk Collaboration on $499 Monthly Ozempic and Wegovy
GoodRx (NASDAQ:GDRX) jumped 18% after revealing a partnership with Novo Nordisk (NYSE:NVO) to offer Ozempic and Wegovy to eligible self-paying patients at a monthly price of $499. This agreement represents a notable price cut for these widely used GLP-1 medications and marks the first time Ozempic is available at this self-pay rate. The program is…